Dashboard
Manage Tickers

BMYBRISTOL MYERS SQUIBB CO

NYSE bms.com


$ 48.72 $ -1.10 (-2.21 %)    

Friday, 06-Sep-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 48.7
$ 48.70 x 100
$ 48.73 x 100
-- - --
$ 39.04 - $ 58.53
11,146,390
na
98.73B
$ 0.50
nm
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-26-2024 06-30-2024 10-Q
2 04-25-2024 03-31-2024 10-Q
3 02-13-2024 12-31-2023 10-K
4 10-26-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 02-14-2023 12-31-2022 10-K
8 10-26-2022 09-30-2022 10-Q
9 07-27-2022 06-30-2022 10-Q
10 04-29-2022 03-31-2022 10-Q
11 02-09-2022 12-31-2021 10-K
12 10-27-2021 09-30-2021 10-Q
13 07-28-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-10-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-24-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 07-25-2019 06-30-2019 10-Q
22 04-25-2019 03-31-2019 10-Q
23 02-25-2019 12-31-2018 10-K
24 10-25-2018 09-30-2018 10-Q
25 07-26-2018 06-30-2018 10-Q
26 04-26-2018 03-31-2018 10-Q
27 02-13-2018 12-31-2017 10-K
28 10-26-2017 09-30-2017 10-Q
29 07-27-2017 06-30-2017 10-Q
30 04-27-2017 03-31-2017 10-Q
31 02-21-2017 12-31-2016 10-K
32 10-27-2016 09-30-2016 10-Q
33 07-28-2016 06-30-2016 10-Q
34 04-28-2016 03-31-2016 10-Q
35 02-12-2016 12-31-2015 10-K
36 10-27-2015 09-30-2015 10-Q
37 07-23-2015 06-30-2015 10-Q
38 04-28-2015 03-31-2015 10-Q
39 02-13-2015 12-31-2014 10-K
40 10-24-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

fda-battles-backlog-of-drug-factory-inspections-since-covid-19
FDA Battles Backlog of Drug Factory Inspec...
09/06/2024 15:52:51

FDA faces inspection backlog with serious public health implications, as critical drug manufacturing plants remain unchecked.

despite-medicare-negotiations-americans-may-still-have-to-pay-more-for-prescription-drugs
Despite Medicare Negotiations, Americans M...
09/03/2024 19:12:09

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly hig...

reported-earlier-bristol-myers-squibb-presents-35-year-data-on-camzyos-at-esc-2024
Reported Earlier, Bristol Myers Squibb Pre...
09/03/2024 07:28:31

Bristol Myers Squibb (NYSE:BMY) today announced new long-term follow-up results from the EXPLORER-LTE cohort of the MAVA-Long-T...

jefferies-maintains-hold-on-bristol-myers-squibb-raises-price-target-to-51
Jefferies Maintains Hold on Bristol-Myers ...
08/28/2024 18:44:01

Jefferies analyst Akash Tewari maintains Bristol-Myers Squibb (NYSE:BMY) with a Hold and raises the price target from $49 to...

as-regulators-gear-up-to-decide-on-bristol-myers-schizophrenia-treatment-neurocrine-biosciences-data-disappoints-investors
As Regulators Gear Up To Decide On Bristol...
08/28/2024 15:16:26

Neurocrine Biosciences reports Phase 2 trial results for NBI-1117568 showing significant improvement in schizophrenia symptoms,...

kohls-posts-upbeat-q2-earnings-joins-box-waldencast-aerovironment-and-other-big-stocks-moving-higher-on-wednesday
Kohl's Posts Upbeat Q2 Earnings, Joins Box...
08/28/2024 14:17:42

regulators-expected-to-approve-innovative-schizophrenia-treatment-from-bristol-myers-karuna
Regulators Expected To Approve Innovative ...
08/27/2024 19:22:11

Drug companies are investing in schizophrenia treatments as patients are desperate for a drug that has few side effects, Bloomb...

market-whales-and-their-recent-bets-on-bmy-options
Market Whales and Their Recent Bets on BMY...
08/27/2024 18:30:48

bristol-myers-squibb-to-present-new-findings-on-camzyos-eliquis-and-milvexian-cardiovascular-treatments-at-esc-congress
Bristol Myers Squibb To Present New Findin...
08/26/2024 11:01:15

Bristol Myers Squibb (NYSE:BMY) today announced the presentation of research across its robust cardiovascular portfolio at the ...

cancer-medicines-from-merck-bristol-myers-and-beigene-in-question-as-fda-committee-to-discuss-limiting-pd-1-drugs-for-stomach-cancer
Cancer Medicines From Merck, Bristol Myers...
08/23/2024 18:10:48

The FDA's Oncologic Drugs Advisory Committee will meet on September 26 to reevaluate the approvals of checkpoint inhibitors...

bristol-myers-squibb-says-fda-schedules-oncologic-drugs-advisory-committee-meeting-for-september-26-to-discuss-pd-l1-expression-levels-in-gastric-and-esophageal-cancers
Bristol-Myers Squibb Says FDA Schedules On...
08/22/2024 19:08:36

- Reuters 

key-takeaways-from-bristol-myers-squibb-analyst-ratings
Key Takeaways From Bristol-Myers Squibb An...
08/22/2024 15:00:16

barclays-maintains-underweight-on-bristol-myers-squibb-raises-price-target-to-42
Barclays Maintains Underweight on Bristol-...
08/22/2024 14:15:41

Barclays analyst Carter Gould maintains Bristol-Myers Squibb (NYSE:BMY) with a Underweight and raises the price target from ...

bristol-myers-squibbs-options-frenzy-what-you-need-to-know
Bristol-Myers Squibb's Options Frenzy: Wha...
08/21/2024 19:46:02

the-fda-has-accepted-bristol-myers-squibbs-supplemental-biologics-license-application-for-opdivo-nivolumab-plus-yervoy-ipilimumab-as-potential-first-line-treatment-for-adult-patients-with-unresectable-hepatocellular-carcinoma-with-prescription-drug-user-fee-act-goal-date-of-april-21-2025
The FDA Has Accepted Bristol Myers Squibb'...
08/21/2024 11:04:30

ema-validates-bristol-myers-squibbs-application-for-breyanzi-in-treating-relapsed-follicular-lymphoma
EMA Validates Bristol Myers Squibb's Appli...
08/19/2024 11:01:52

Bristol Myers Squibb (NYSE:BMY) today announced that the European Medicines Agency (EMA) has validated its Type II variation ap...

check-out-what-whales-are-doing-with-bmy
Check Out What Whales Are Doing With BMY
08/16/2024 17:16:30

biden-administration-targets-6b-savings-through-medicare-drug-price-negotiations
Biden Administration Targets $6B Savings T...
08/15/2024 14:38:21

Medicare drug price negotiations, enabled by the Inflation Reduction Act, are set to save the U.S. government $6 billion.

bristol-myers-german-partner-evotec-plans-layoffs-cites-challenging-revenues-profitability
Bristol Myers' German Partner Evotec Plans...
08/14/2024 18:30:37

Evotec reports a rise in Q2 sales to $201.12M but posts an EPS loss of $0.54. CEO Christian Wojczewski cites market challenges ...

cancer-focused-syros-pharmaceuticals-stops-mid-stage-leukemia-combo-therapy-study-cites-disappointing-unexpected-outcome
Cancer-Focused Syros Pharmaceuticals Stops...
08/13/2024 13:41:17

Syros Pharmaceuticals announces discontinuing enrollment in the SELECT-AML-1 Phase 2 trial due to the low probability of demons...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION